BioSpace News Archive

Bio NC

BioCryst to Present at Upcoming September 2023 Investor Conferences

BioCryst Pharmaceuticals, Inc. announced that the company will present at the 2023 Wells Fargo Healthcare Conference on Wednesday, September 6th in Boston at 3:00 p.m. ET and the H.C. Wainwright 25th Annual Global Investment Conference on Wednesday, September 13th in New York at 12:30 p.m. ET.

August 23, 2023
·
1 min read
Lone Star Bio

Omnicell to Present at the 2023 Wells Fargo Healthcare Conference

Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, announced that it will present at the 2023 Wells Fargo Healthcare Conference on Wednesday, September 6, 2023 at 3:00 p.m. ET.

August 23, 2023
·
1 min read
Business

Exelixis Announces Appointment of Amy Peterson, M.D., as Executive Vice President, Product Development & Medical Affairs, and Chief Medical Officer

Exelixis, Inc. announced it has appointed Amy Peterson, M.D., its next Executive Vice President, Product Development & Medical Affairs, and Chief Medical Officer.

August 23, 2023
·
4 min read
Biotech Bay

Vaxxas Awarded US$3.67 million (AU$5.4 million) from global charitable foundation, Wellcome, for Human Clinical Study of Typhoid Vaccination using Needle-Free Vaccine Patch

Vaxxas announced that the global charitable foundation, Wellcome, has made an award totaling US$3.67 million to conduct IND-enabling studies and a first-in-human clinical study for a potentially second generation typhoid vaccine delivered by Vaxxas’ proprietary high-density microarray patch platform technology.

August 23, 2023
·
8 min read
Policy

Medtronic issues statement on the FDA Circulatory Systems Devices Advisory Panel vote for the Symplicity Spyral Renal Denervation System

Medtronic announced the outcome of the U.S. Food & Drug Administration Circulatory System Devices Panel meeting to review data presented in support of the Medtronic Symplicity Spyral™ Renal Denervation System.

August 23, 2023
·
4 min read